The phosphorylation status and cytoskeletal remodeling of striatal astrocytes treated with quinolinic acid

Experimental Cell Research

Volumn 322, Issue 2, 2014, Pages 313-323

  Pierozan, Paula ^a   Ferreira, Fernanda ^a   Ortiz de Lima, Bárbara ^a   Gonçalves Fernandes, Carolina ^a   Totarelli Monteforte, Priscila ^b   De Castro Medaglia, Natalia ^b   Bincoletto, Claudia ^b   Soubhi Smaili, Soraya ^b   Pessoa Pureur, Regina ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Astrocyte, cell signaling; Cytoskeleton remodelling; GFAP phosphorylation; Quinolinic acid

Indexed keywords

2 AMINO 5 PHOSPHONOVALERIC ACID; 6 CYANO 7 NITRO 2,3 QUINOXALINEDIONE; CALCIUM; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; CYCLIC AMP DEPENDENT PROTEIN KINASE INHIBITOR; EGTAZIC ACID; ETHYLENE GLYCOL 1,2 BIS(2 AMINOPHENYL) ETHER N,N,N',N' TETRAACETIC ACID; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATE RECEPTOR ANTAGONIST; KYNURENINE; METABOTROPIC RECEPTOR 1; METABOTROPIC RECEPTOR 5; N [2 (4 BROMOCINNAMYLAMINO)ETHYL] 5 ISOQUINOLINESULFONAMIDE; N [2 [[N [3 (4 CHLOROPHENYL) 2 PROPENYL] N METHYLAMINO]METHYL]PHENYL] N (2 HYDROXYETHYL) 4 METHOXYBENZENESULFONAMIDE; PHOSPHATE; PROTEIN KINASE C INHIBITOR; QUINOLINIC ACID; STAUROSPORINE; TRYPTOPHAN; VERAPAMIL; VIMENTIN;

ACTIN FILAMENT; ANIMAL CELL; ARTICLE; ASTROCYTE; CALCIUM TRANSPORT; CELL STRUCTURE; CONTROLLED STUDY; CORPUS STRIATUM; CYTOPLASM; CYTOSKELETON; EXCITOTOXICITY; FEMALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT;

ASTROCYTE, CELL SIGNALING; CYTOSKELETON REMODELLING; GFAP PHOSPHORYLATION; QUINOLINIC ACID;

ACTIN CYTOSKELETON; ANIMALS; APOPTOSIS; ASTROCYTES; BLOTTING, WESTERN; CALCIUM; CELL PROLIFERATION; CELLS, CULTURED; CORPUS STRIATUM; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; GLUTAMATES; IMMUNOENZYME TECHNIQUES; PHOSPHORYLATION; PREGNANCY; QUINOLINIC ACID; RATS; RATS, WISTAR; VIMENTIN;

EID: 84896030152     PISSN: 00144827     EISSN: 10902422     Source Type: Journal    
DOI: 10.1016/j.yexcr.2014.02.024     Document Type: Article

References (76)

1. Heyes M.P. Quinolinic acid and inflammation. Ann. N. Y. Acad. Sci. 1993, 679:211-216.
2. Guidetti P., Luthi-Carter R.E., Augood S.J., Schwarcz R. Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease. Neurobiol. Dis. 2004, 17:455-461.
3. Baran H., Jellinger K., Deecke L. Kynurenine metabolism in Alzheimer's disease. J. Neural Transm. 1999, 106:165-181.
4. Widner B., Leblhuber F., Walli J., Tilz G.P., Demel U., Fuchs D. Tryptophan degradation and immune activation in Alzheimer's disease. J. Neural Transm. 2000, 107:343-353.
5. Stone T.W. Neuropharmacology of quinolinic and kynurenic acids. Pharmacol. Rev. 1993, 45:309-379.
6. Guillemin G.J. Quinolinic acid, the inescapable neurotoxin. FEBS J. 2012, 279:1356-1365.
7. Perez-De La Cruz V., Carrillo-Mora P., Santamaria A. Quinolinic acid, an endogenous molecule combining excitotoxicity, oxidative stress and other toxic mechanisms. Int. J. Tryptophan Res. 2012, 5:1-8.
8. Rahman A., Ting K., Cullen K.M., Braidy N., Brew B.J., Guillemin G.J. The excitotoxin quinolinic acid induces tau phosphorylation in human neurons. PLoS One 2009, 4:e6344.
9. Pierozan P., Zamoner A., Soska A.K., Silvestrin R.B., Loureiro S.O., Heimfarth L., Mello e Souza T., Wajner M., Pessoa-Pureur R. Acute intrastriatal administration of quinolinic acid provokes hyperphosphorylation of cytoskeletal intermediate filament proteins in astrocytes and neurons of rats. Exp. Neurol. 2010, 224:188-196.
10. Pierozan P., Zamoner A., Soska A.K., de Lima B.O., Reis K.P., Zamboni F., Wajner M., Pessoa-Pureur R. Signaling mechanisms downstream of quinolinic acid targeting the cytoskeleton of rat striatal neurons and astrocytes. Exp. Neurol. 2012, 233:391-399.
11. Middeldorp J., Hol E.M. GFAP in health and disease. Prog. Neurobiol. 2011, 93:421-443.
12. Zamoner A., Pessoa-Pureur R. Nongenomic Actions of Thyroid Hormones: Every Why has a Wherefore. IEMA-MC 2011, 165-178.
13. Arbustini E., Pasotti M., Pilotto A., Pellegrini C., Grasso M., Previtali S., Repetto A., Bellini O., Azan G., Scaffino M., Campana C., Piccolo G., Vigano M., Tavazzi L. Desmin accumulation restrictive cardiomyopathy and atrioventricular block associated with desmin gene defects. Eur. J. Heart Fail 2006, 8:477-483.
14. Fabrizi G.M., Cavallaro T., Angiari C., Bertolasi L., Cabrini I., Ferrarini M., Rizzuto N. Giant axon and neurofilament accumulation in Charcot-Marie-Tooth disease type 2E. Neurology 2004, 62:1429-1431.
15. Figlewicz D.A., Krizus A., Martinoli M.G., Meininger V., Dib M., Rouleau G.A., Julien J.P. Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum. Mol. Genet. 1994, 3:1757-1761.
16. Hertel L. Herpesviruses and intermediate filaments: close encounters with the third type. Viruses 2011, 3:1015-1040.
17. Heimfarth L., Loureiro S.O., Dutra M.F., Andrade C., Pettenuzzo L., Guma F.T., Goncalves C.A., da Rocha J.B., Pessoa-Pureur R. In vivo treatment with diphenyl ditelluride induces neurodegeneration in striatum of young rats: implications of MAPK and Akt pathways. Toxicol. Appl. Pharmacol. 2012, 264:143-152.
18. Heimfarth L., Loureiro S.O., Dutra M.F., Petenuzzo L., de Lima B.O., Fernandes C.G., da Rocha J.B., Pessoa-Pureur R. Disrupted cytoskeletal homeostasis, astrogliosis and apoptotic cell death in the cerebellum of preweaning rats injected with diphenyl ditelluride. Neurotoxicology 2013, 34:175-188.
19. Heimfarth L., Loureiro S.O., Reis K.P., de Lima B.O., Zamboni F., Gandolfi T., Narvaes R., da Rocha J.B., Pessoa-Pureur R. Cross-talk among intracellular signaling pathways mediates the diphenyl ditelluride actions on the hippocampal cytoskeleton of young rats. Chem. Res. Toxicol. 2011, 24:1754-1764.
20. Heimfarth L., Loureiro S.O., Reis K.P., de Lima B.O., Zamboni F., Lacerda S., Soska A.K., Wild L., da Rocha J.B., Pessoa-Pureur R. Diphenyl ditelluride induces hypophosphorylation of intermediate filaments through modulation of DARPP-32-dependent pathways in cerebral cortex of young rats. Arch. Toxicol. 2012, 86:217-230.
21. Grant P., Pant H.C. Neurofilament protein synthesis and phosphorylation. J. Neurocytol. 2000, 29:843-872.
22. Sihag R.K., Inagaki M., Yamaguchi T., Shea T.B., Pant H.C. Role of phosphorylation on the structural dynamics and function of types III and IV intermediate filaments. Exp. Cell Res. 2007, 313:2098-2109.
23. Zamoner A., Funchal C., Heimfarth L., Silva F.R., Pessoa-Pureur R. Short-term effects of thyroid hormones on cytoskeletal proteins are mediated by GABAergic mechanisms in slices of cerebral cortex from young rats. Cell. Mol. Neurobiol. 2006, 26:209-224.
24. Zanatta L., Goulart P.B., Goncalves R., Pierozan P., Winkelmann-Duarte E.C., Woehl V.M., Pessoa-Pureur R., Silva F.R., Zamoner A. 1Alpha,25-dihydroxyvitamin D(3) mechanism of action: modulation of L-type calcium channels leading to calcium uptake and intermediate filament phosphorylation in cerebral cortex of young rats. Biochim. Biophys. Acta 2012, 1823:1708-1719.
25. Nishizawa K., Yano T., Shibata M., Ando S., Saga S., Takahashi T., Inagaki M. Specific localization of phosphointermediate filament protein in the constricted area of dividing cells. J. Biol. Chem. 1991, 266:3074-3079.
26. Matsuoka Y., Nishizawa K., Yano T., Shibata M., Ando S., Takahashi T., Inagaki M. Two different protein kinases act on a different time schedule as glial filament kinases during mitosis. EMBO J. 1992, 11:2895-2902.
27. Inagaki M., Gonda Y., Nishizawa K., Kitamura S., Sato C., Ando S., Tanabe K., Kikuchi K., Tsuiki S., Nishi Y. Phosphorylation sites linked to glial filament disassembly in vitro locate in a non-alpha-helical head domain. J. Biol. Chem. 1990, 265:4722-4729.
28. Eddleston M., Mucke L. Molecular profile of reactive astrocytes-implications for their role in neurologic disease. Neuroscience 1993, 54:15-36.
29. Nawashiro H., Brenner M., Fukui S., Shima K., Hallenbeck J.M. High susceptibility to cerebral ischemia in GFAP-null mice. J. Cereb. Blood Flow Metab. 2000, 20:1040-1044.
30. Madathil S.K., Carlson S.W., Brelsfoard J.M., Ye P., D'Ercole A.J., Saatman K.E. Astrocyte-specific overexpression of insulin-like growth factor-1 protects hippocampal neurons and reduces behavioral deficits following traumatic brain injury in mice. PLoS One 2013, 8:e67204.
31. Frederickson R.C. Astroglia in Alzheimer's disease. Neurobiol. Aging 1992, 13:239-253.
32. Aschner M., Kimelberg H.K. The use of astrocytes in culture as model systems for evaluating neurotoxic-induced-injury. Neurotoxicology 1991, 12:505-517.
33. Loureiro S.O., Romao L., Alves T., Fonseca A., Heimfarth L., Moura Neto V., Wyse A.T., Pessoa-Pureur R. Homocysteine induces cytoskeletal remodeling and production of reactive oxygen species in cultured cortical astrocytes. Brain Res. 2010, 1355:151-164.
34. Bruno V., Battaglia G., Casabona G., Copani A., Caciagli F., Nicoletti F. Neuroprotection by glial metabotropic glutamate receptors is mediated by transforming growth factor-beta. J. Neurosci. 1998, 18:9594-9600.
35. Takagi N., Besshoh S., Marunouchi T., Takeo S., Tanonaka K. Metabotropic glutamate receptor 5 activation enhances tyrosine phosphorylation of the N-methyl-d-aspartate (NMDA) receptor and NMDA-induced cell death in hippocampal cultured neurons. Biol. Pharm. Bull. 2012, 35:2224-2229.
36. Tang M., Wang M., Xing T., Zeng J., Wang H., Ruan D.Y. Mechanisms of unmodified CdSe quantum dot-induced elevation of cytoplasmic calcium levels in primary cultures of rat hippocampal neurons. Biomaterials 2008, 29:4383-4391.
37. Yuan Y., Jiang C.Y., Xu H., Sun Y., Hu F.F., Bian J.C., Liu X.Z., Gu J.H., Liu Z.P. Cadmium-induced apoptosis in primary rat cerebral cortical neurons culture is mediated by a calcium signaling pathway. PLoS One 2013, 8:e64330.
38. Kurusu S., Matsui K., Watanabe T., Tsunou T., Kawaminami M. The cytotoxic effect of bromoenol lactone, a calcium-independent phospholipase A2 inhibitor, on rat cortical neurons in culture. Cell. Mol. Neurobiol. 2008, 28:1109-1118.
39. Masmoudi O., Gandolfo P., Tokay T., Leprince J., Ravni A., Vaudry H., Tonon M.C. Somatostatin down-regulates the expression and release of endozepines from cultured rat astrocytes via distinct receptor subtypes. J. Neurochem. 2005, 94:561-571.
40. Chong Y.H., Lee M.J. Effect of HIV-1 gp41 peptides on secretion of beta-amyloid precursor protein in human astroglial cell line, T98G. J. Mol. Neurosci. 1999, 12:147-156.
41. Kao C.Q., Goforth P.B., Ellis E.F., Satin L.S. Potentiation of GABA(A) currents after mechanical injury of cortical neurons. J. Neurotrauma 2004, 21:259-270.
42. Dong Y., Liu H.D., Zhao R., Yang C.Z., Chen X.Q., Wang X.H., Lau L.T., Chen J., Yu A.C. Ischemia activates JNK/c-Jun/AP-1 pathway to up-regulate 14-3-3gamma in astrocyte. J. Neurochem. 2009, 109(Suppl. 1):182-188.
43. Cha Y.K., Kim Y.H., Ahn Y.H., Koh J.Y. Epidermal growth factor induces oxidative neuronal injury in cortical culture. J. Neurochem. 2000, 75:298-303.
44. Maldonado H., Ramirez E., Utreras E., Pando M.E., Kettlun A.M., Chiong M., Kulkarni A.B., Collados L., Puente J., Cartier L., Valenzuela M.A. Inhibition of cyclin-dependent kinase 5 but not of glycogen synthase kinase 3-beta prevents neurite retraction and tau hyperphosphorylation caused by secretable products of human T-cell leukemia virus type I-infected lymphocytes. J. Neurosci. Res. 2011, 89:1489-1498.
45. Funchal C., de Almeida L.M., Oliveira Loureiro S., Vivian L., de Lima Pelaez P., Dall Bello Pessutto F., Rosa A.M., Wajner M., Pessoa Pureur R. In vitro phosphorylation of cytoskeletal proteins from cerebral cortex of rats. Brain Res. Brain Res. Protoc. 2003, 11:111-118.
46. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
47. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970, 227:680-685.
48. Omary M.B., Ku N.O., Tao G.Z., Toivola D.M., Liao J. Heads and tails of intermediate filament phosphorylation: multiple sites and functional insights. Trends Biochem. Sci. 2006, 31:383-394.
49. Gourlay C.W., Ayscough K.R. The actin cytoskeleton: a key regulator of apoptosis and ageing?. Nat. Rev. Mol. Cell Biol. 2005, 6:583-589.
50. Guillemin G.J., Wang L., Brew B.J. Quinolinic acid selectively induces apoptosis of human astrocytes: potential role in AIDS dementia complex. J. Neuroinflammation 2005, 2:16.
51. Braidy N., Grant R., Adams S., Brew B.J., Guillemin G.J. Mechanism for quinolinic acid cytotoxicity in human astrocytes and neurons. Neurotox. Res. 2009, 16:77-86.
52. Braidy N., Grant R., Brew B.J., Adams S., Jayasena T., Guillemin G.J. Effects of Kynurenine pathway metabolites on intracellular NAD synthesis and cell death in human primary astrocytes and neurons. Int. J. Tryptophan Res. 2009, 2:61-69.
53. Liu B., Dong Q., Zhang S., Su D., Yang Z., Lv M. mGluR1,5 activation protects cortical astrocytes and GABAergic neurons from ischemia-induced impairment. Neurosci. Res. 2013, 75:160-166.
54. Schwarcz R., Pellicciari R. Manipulation of brain kynurenines: glial targets, neuronal effects, and clinical opportunities. J. Pharmacol. Exp. Ther. 2002, 303:1-10.
55. Severino P.C., Muller Gdo A., Vandresen-Filho S., Tasca C.I. Cell signaling in NMDA preconditioning and neuroprotection in convulsions induced by quinolinic acid. Life Sci. 2011, 89:570-576.
56. Lee M.C., Ting K.K., Adams S., Brew B.J., Chung R., Guillemin G.J. Characterisation of the expression of NMDA receptors in human astrocytes. PLoS One 2010, 5:e14123.
57. Steiner D., Saya D., Schallmach E., Simonds W.F., Vogel Z. Adenylyl cyclase type-VIII activity is regulated by G(betagamma) subunits. Cell Signal 2006, 18:62-68.
58. Kind P.C., Neumann P.E. Plasticity: downstream of glutamate. Trends Neurosci. 2001, 24:553-555.
59. Husi H., Ward M.A., Choudhary J.S., Blackstock W.P., Grant S.G. Proteomic analysis of NMDA receptor-adhesion protein signaling complexes. Nat. Neurosci. 2000, 3:661-669.
60. Westphal R.S., Tavalin S.J., Lin J.W., Alto N.M., Fraser I.D., Langeberg L.K., Sheng M., Scott J.D. Regulation of NMDA receptors by an associated phosphatase-kinase signaling complex. Science 1999, 285:93-96.
61. Cooper D.M., Mons N., Karpen J.W. Adenylyl cyclases and the interaction between calcium and cAMP signalling. Nature 1995, 374:421-424.
62. Wang H., Zhuo M. Group I metabotropic glutamate receptor-mediated gene transcription and implications for synaptic plasticity and diseases. Front Pharmacol. 2012, 3:189.
63. Dell'anno M.T., Pallottino S., Fisone G. mGlu5R promotes glutamate AMPA receptor phosphorylation via activation of PKA/DARPP-32 signaling in striatopallidal medium spiny neurons. Neuropharmacology 2013, 66:179-186.
64. Malinow R., Malenka R.C. AMPA receptor trafficking and synaptic plasticity. Annu. Rev. Neurosci. 2002, 25:103-126.
65. Van Troys M., Huyck L., Leyman S., Dhaese S., Vandekerkhove J., Ampe C. Ins and outs of ADF/cofilin activity and regulation. Eur. J. Cell Biol. 2008, 87:649-667.
66. Nadella K.S., Saji M., Jacob N.K., Pavel E., Ringel M.D., Kirschner L.S. Regulation of actin function by protein kinase A-mediated phosphorylation of Limk1. EMBO Rep. 2009, 10:599-605.
67. Goeckeler Z.M., Wysolmerski R.B. Myosin phosphatase and cofilin mediate cAMP/cAMP-dependent protein kinase-induced decline in endothelial cell isometric tension and myosin II regulatory light chain phosphorylation. J. Biol. Chem. 2005, 280:33083-33095.
68. Meberg P.J., Ono S., Minamide L.S., Takahashi M., Bamburg J.R. Actin depolymerizing factor and cofilin phosphorylation dynamics: response to signals that regulate neurite extension. Cell Motil. Cytoskeleton 1998, 39:172-190.
69. Ridet J.L., Malhotra S.K., Privat A., Gage F.H. Reactive astrocytes: cellular and molecular cues to biological function. Trends Neurosci. 1997, 20:570-577.
70. Silver J., Miller J.H. Regeneration beyond the glial scar. Nat. Rev. Neurosci. 2004, 5:146-156.
71. Buffo A., Rolando C., Ceruti S. Astrocytes in the damaged brain: molecular and cellular insights into their reactive response and healing potential. Biochem. Pharmacol. 2010, 79:77-89.
72. Hisanaga S., Gonda Y., Inagaki M., Ikai A., Hirokawa N. Effects of phosphorylation of the neurofilament L protein on filamentous structures. Cell Regul. 1990, 1:237-248.
73. Hisanaga S., Matsuoka Y., Nishizawa K., Saito T., Inagaki M., Hirokawa N. Phosphorylation of native and reassembled neurofilaments composed of NF-L, NF-M, and NF-H by the catalytic subunit of cAMP-dependent protein kinase. Mol. Biol. Cell. 1994, 5:161-172.
74. Hayashi H., Campenot R.B., Vance D.E., Vance J.E. Protection of neurons from apoptosis by apolipoprotein E-containing lipoproteins does not require lipoprotein uptake and involves activation of phospholipase Cgamma1 and inhibition of calcineurin. J. Biol. Chem. 2009, 284:29605-29613.
75. Volterra A., Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 2005, 6:626-640.
76. Yamanaka K., Chun S.J., Boillee S., Fujimori-Tonou N., Yamashita H., Gutmann D.H., Takahashi R., Misawa H., Cleveland D.W. Astrocytes as determinants of disease progression in inherited amyotrophic lateral sclerosis. Nat. Neurosci. 2008, 11:251-253.